NCT02873559

Brief Summary

In this scientific clinical investigation we will test whether testosterone and progressive resistance training can improve muscle strength and reduce the risk of falls in older men. In addition, we will examine whether this treatment improves quality of life, functional capacity, including sexual function and counteracts depression. Such a project have not been performed earlier.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
192

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started Nov 2016

Longer than P75 for phase_2

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 12, 2016

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 19, 2016

Completed
2 months until next milestone

Study Start

First participant enrolled

November 1, 2016

Completed
5.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2022

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2023

Completed
Last Updated

May 29, 2024

Status Verified

May 1, 2024

Enrollment Period

5.4 years

First QC Date

August 12, 2016

Last Update Submit

May 28, 2024

Conditions

Keywords

olderfrailmenprogressive muscle trainingmuscle trainingexercisetestosterone

Outcome Measures

Primary Outcomes (1)

  • Stand-up-and Sit-test

    It is a measure of overall strength in the lower extremities. Result of the test is defined as the number of times the participant can stand up and sit from a chair in 30 seconds. There is a good correlation (r = 0.78) with a leg press and an acceptable test-retest reliability (ICC = 0.86).

    up to 5 months (at study completion)

Secondary Outcomes (35)

  • Frequency and severity of falls via questionaire

    At baseline, 1 month, 5 months (at study completion)

  • Balance ability,

    At baseline, 1 month, 5 months (at study completion)

  • Avlund mobility scale

    At baseline, 1 month, 5 months (at study completion)

  • Leg extensor Power Rig test

    At baseline, 1 month, 5 months (at study completion)

  • Isometric muscle strength

    At baseline, 1 month, 5 months (at study completion)

  • +30 more secondary outcomes

Study Arms (4)

Controls

NO INTERVENTION

A control group, which is 20 weeks with placebo injections without training.

Testosterone

EXPERIMENTAL

A testosterone group given 20 weeks on testosterone injections without training

Drug: testosterone

Training

EXPERIMENTAL

A Training Group, which is 20 weeks with placebo injections and 16 weeks of progressive resistance training supplemented with vitamin D and protein supplements

Other: Progressive muscle training

Testosterone and training

EXPERIMENTAL

A combination group that is 20 weeks with testosterone injections and 16 weeks of progressive resistance training supplemented with vitamin D and protein supplements

Drug: testosteroneOther: Progressive muscle training

Interventions

Testosterone supplemented in 5 months

TestosteroneTestosterone and training

Progressive muscle training during 4 months

Also known as: Training
Testosterone and trainingTraining

Eligibility Criteria

Age70 Years+
Sexmale
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • Living in their own home or in sheltered accommodation. Independent gait possible. with tool. Capable of stand-up and sit in a chair at least 8 times in 30 sec. There must be at least 3 symptoms or objective findings of low testosterone . Serum testosterone \<10nmol /L as the average of two independent measurements

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Karsten Overgaard

Hellerup, Danmark, DK-2900, Denmark

Location

Medical Dept. O, Geriatric Section

Herlev, 2730, Denmark

Location

Related Publications (2)

  • Rasmussen RS, Midttun M, Zerahn B, Pedersen M, Rashid A, Ostergren PB, Paulin TK, Podenphanth TW, Karlsson LK, Rosendahl E, Ragle AM, Vinther A, Overgaard K. Testosterone and resistance training improved physical performance and reduced fatigue in frail older men: 1 year follow-up of a randomized clinical trial. Aging Male. 2024 Dec;27(1):2403519. doi: 10.1080/13685538.2024.2403519. Epub 2024 Sep 17.

  • Rasmussen R, Midttun M, Kolenda T, Ragle AM, Sorensen TW, Vinther A, Zerahn B, Pedersen M, Overgaard K. Therapist-Assisted Progressive Resistance Training, Protein Supplements, and Testosterone Injections in Frail Older Men with Testosterone Deficiency: Protocol for a Randomized Placebo-Controlled Trial. JMIR Res Protoc. 2018 Mar 2;7(3):e71. doi: 10.2196/resprot.8854.

Related Links

MeSH Terms

Conditions

Muscle WeaknessMultiple Endocrine Neoplasia Type 1Motor Activity

Interventions

TestosteroneAutogenic Training

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsMultiple Endocrine NeoplasiaEndocrine Gland NeoplasmsNeoplasms by SiteNeoplasmsNeoplasms, Multiple PrimaryNeoplastic Syndromes, HereditaryGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesEndocrine System DiseasesBehavior

Intervention Hierarchy (Ancestors)

AndrostenolsAndrostenesAndrostanesSteroidsFused-Ring CompoundsPolycyclic CompoundsTestosterone CongenersGonadal Steroid HormonesGonadal HormonesHormonesHormones, Hormone Substitutes, and Hormone AntagonistsHypnosisMind-Body TherapiesComplementary TherapiesTherapeuticsPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Karsten Overgaard, M.D.

    Herlev Hospital, Neurological Department N108

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Neuropychologist, Ph.D., associate professor

Study Record Dates

First Submitted

August 12, 2016

First Posted

August 19, 2016

Study Start

November 1, 2016

Primary Completion

March 31, 2022

Study Completion

March 1, 2023

Last Updated

May 29, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations